Jun Morita

7PUBLICATIONS
5CO-AUTHORS
PharmacogenomicsNanomedicineEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 09, 2026
Evaluation of drug-drug interaction between nacubactam and β-lactam antibiotic (cefepime, aztreonam, meropenem, or piperacillin) in Japanese healthy participants.

|Jun 05, 2026
Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection.

|May 25, 2026
Effects of Nacubactam and Its Metabolites on QTc Interval: A Pooled Analysis of Two Randomized Phase 1 Studies.

|Apr 30, 2026
Evidence of intrapulmonary penetration of nacubactam, a novel β-lactamase inhibitor, following coadministration of nacubactam with meropenem in healthy adults.

|Apr 30, 2026
A multi-center, open-label, two-part study to investigate the effect of renal function and hemodialysis on the pharmacokinetics of the novel β-lactamase inhibitor nacubactam.

|Apr 13, 2026
Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants.

Jun Morita, Noriko Hida, Takuma Yonemura

Pageof 2

Frequent Collaborators

2 joint publications

Navita L Mallalieu

1 joint publications

Noriko Hida

1 joint publications

Naoki Uchida

1 joint publications

Sue McKendrick